Home > Insider Trading > Filing (0001214659-24-004389)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1398733	Aquestive Therapeutics Inc.	AQST	Pharmaceutical Preparations (2834)	208623253

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1406836	Mark Alexander Schobel	C/O Aquestive Therapeutics, Inc. 30 Technology Drive Warren NJ 07059	Chief Innovation/Tech Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-03-08	25,000	$5.19	1,040,371	No	4	S	Direct
Common Stock	Disposition	2024-03-09	5,895	$4.88	1,034,476	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	F	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2023.
Represents the weighted average sales price per share. The shares sold at prices ranging from $5.00 to $5.60 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.